Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
36,199,999
-
Shares change
-
-1,704,991
-
Total reported value, excl. options
-
$166,471,159
-
Value change
-
-$8,903,915
-
Put/Call ratio
-
55.63%
-
Number of buys
-
58
-
Number of sells
-
-61
-
Price
-
$4.6
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2021
165 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q4 2021.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,199,999 shares
of 113,177,462 outstanding shares and own 31.99% of the company stock.
Largest 10 shareholders include ArrowMark Colorado Holdings LLC (7,060,803 shares), BlackRock Inc. (5,119,490 shares), STATE STREET CORP (4,125,567 shares), VANGUARD GROUP INC (3,384,167 shares), Park West Asset Management LLC (1,618,587 shares), GEODE CAPITAL MANAGEMENT, LLC (1,181,655 shares), DIMENSIONAL FUND ADVISORS LP (1,063,108 shares), TWO SIGMA INVESTMENTS, LP (933,481 shares), TWO SIGMA ADVISERS, LP (878,428 shares), and NORTHERN TRUST CORP (857,774 shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.